mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |